Table 3. Between-Groups Comparison.
ROI |
Group |
|||||||
---|---|---|---|---|---|---|---|---|
Measurea | MDMA (mean±SD) | Non-MDMA (mean±SD) | p-Value* | High-MDMA (mean±SD) | p-Value** | Low-MDMA (mean±SD) | p-Value*** | |
LGN | Signal intensity | 0.014±0.030 | 0.031±0.045 | 0.221 | 0.033±0.016 | 0.713 | −0.006±0.027 | 0.015 |
BA 17 | Signal intensity | 0.121±0.104 | 0.132±0.124 | 0.989 | 0.170±0.114 | 0.248 | 0.068±0.022 | 0.248 |
Spatial extent | 32.210±32.48 | 24.53±25.63 | 0.478 | 51.899±33.491 | 0.031b | 12.529±15.633 | 0.328 | |
BA 18 | Signal intensity | 0.089±0.070 | 0.091±0.085 | 0.904 | 0.1204±0.082 | 0.475 | 0.057±0.038 | 0.350 |
Spatial extent | 26.685±29.533 | 17.863±20.200 | 0.529 | 43.227±33.174 | 0.049 | 10.143±11.520 | 0.373 |
Abbreviations: BA, Brodmann Area; LGN, lateral geniculate nucleus; ROI, region of interest; SD, standard deviation of the mean.
Data are presented as mean percent signal intensity or spatial extent (activated voxels) in an ROI. Spatial extent data is not reported for LGN because no activated voxels were detected in LGN using corrected statistical thresholds. Between-group comparisons were performed using Mann–Whitney U-test for non-parametric data.
Bolded text, significant at p<0.05.
*p-Value represents comparison of entire MDMA group to non-MDMA control group.
**p-Value represents comparison of high-exposure MDMA subgroup to non-MDMA control group.
***p-Value represents comparison of low-exposure MDMA subgroup to non-MDMA control group.